 Histological inflammation in patients with Benign Prostatic Hyperplasia BPH appears to predict clinical progression and ultimate long-term response to various medical therapies, including finasteride. Discovery of a urine or serum marker of prostate inflammation will be an invaluable clinical tool to predict a mans risk of BPH progression and the efficacy of various medical therapies to reduce that risk. 